-
Most Recent
Search Results
240 results for VTENX
Why Vanguard’s Special Retirement Funds Are a Rip-Off
Investing in Vanguard’s “life-cycle” funds may feel like you’re doing your money some good, but in fact you could simply be spinning your wheels —…
Target-Date Funds – How Does Yours Add Up?
Here we identify and rank the best performers among target-date mutual funds.
3 Best Mutual Funds for Stingy Retirees
Retirees looking for steady, generous income and low risk too often pay punishingly high fees. These low-risk income funds can’t be beat on price.
VTEX Stock Earnings: Vtex Misses Revenue for Q1 2024
VTEX stock results show that Vtex missed on revenue for the first quarter of 2024.
Why Is Tenax Therapeutics (TENX) Stock Up 300% Today?
Although Tenax Therapeutics has received a green light for its investigational drug, investors should exercise caution with TENX stock.
Why Is Tenax Therapeutics (TENX) Stock Down 64% Today?
Tenax Therapeutics stock is falling on Thursday after the company announced the pricing of a public offering for TENX shares.
VTEX Stock Earnings: Vtex Beats EPS, Beats Revenue for Q2 2024
VTEX stock results show that Vtex beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
4 Funds to Play the Energy Market
Despite the weakness in energy of late, the industry and energy commodities should be a solid long-term investment — and you can get exposure through…
Why Is Tenax Therapeutics (TENX) Stock On the Move Today?
Tenax Therapeutics (TENX) stock is on the move Wednesday after the company announced plans for a one-for-20 reverse stock split.
3 Best Vanguard Funds for 2015
Check out our list of the best Vanguard funds for 2015 to make sure you get the highest returns for the lowest cost.
TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Precision Med as Shares Rocket
Tenax Therapeutics (TENX) stock is flying high on Tuesday after announcing it has acquired biotech company PH Precision Med.
5 Stocks With Ugly Sales Growth — RNA EXAS GNCA NBIX TENX
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.
Bucking the Trend: 3 Stocks That Zoomed While the Market Crashed
Even as the market crashed last week there were some outperforming stocks that went on to double- and triple-digit gains.
Why Is Tenax Therapeutics (TENX) Stock Up 29% Today?
Tenax Therapeutics stock is up on Tuesday after the company revealed an oversubscribed private placement for TENX shares.
Why These 5 Mutual Funds Are Beating the S&P 500
We look at five mutual funds significantly beating the S&P 500 Index in 2014 — and more importantly, what this strong outperformance means.
Vanguard Sector Funds
These four low-cost Vanguard sector funds can be smart choices to strengthen your portfolio with tactical exposure.
5 Funds That Should Fly on QE3
A rising QE3 tide might not lift all boats, but it’ll lift a few. From utilities to commodities, investors can ride Bernanke’s wave atop these…
7 Biotechnology Stocks to Sell Now
The ratings of seven biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
Why Is Tenax Therapeutics (TENX) Stock Up 149% Today?
Tenax Therapeutics (TENX) stock is rocketing higher on Thursday after getting an update on one of its U.S. medical patents.
1 – 10 of 240 results
